Abstract:Abstract Background Unphosphorylated signal transducer and activator of transcription 1 (U-STAT1) has been reported to elicit a distinct gene expression profile as compared to tyrosine-phosphorylated STAT1 (P-STAT1) homodimers. However, the impact of U-STAT1 on the IFNγ-induced immune response mediated by P-STAT1 is unknown. By generating a double mutant of STAT1 with mutation R602L in the Src-homology 2 (SH2) domain and Y701F in the carboxy-terminal transactivation domain mimicking U-STAT1, we investigated the effects of U-STAT1 on P-STAT1-mediated signal transduction. Results In this study, we discovered a novel activity of U-STAT1 that alters the nucleo-cytoplasmic distribution of cytokine-stimulated P-STAT1. While the dimerization-deficient mutant R602L/Y701F was not able to display cytokine-induced nuclear accumulation, it inhibited the nuclear accumulation of co-expressed IFNγ-stimulated wild-type P-STAT1. Disruption of the anti-parallel dimer interface in the R602L/Y701F mutant via additional R274W and T385A mutations did not rescue the impaired nuclear accumulation of co-expressed P-STAT1. The mutant U-STAT1 affected neither the binding of co-expressed P-STAT1 to gamma-activated sites in vitro, nor the transcription of reporter constructs and the activation of STAT1 target genes. However, the nuclear accumulation of P-STAT1 was diminished in the presence of mutant U-STAT1, which was not restored by mutations reducing the DNA affinity of mutant U-STAT1. Whereas single mutations in the amino-terminus of dimerization-deficient U-STAT1 similarly inhibited the nuclear accumulation of co-expressed P-STAT1, a complete deletion of the amino-terminus restored cytokine-stimulated nuclear accumulation of P-STAT1. Likewise, the disruption of a dimer-specific nuclear localization signal also rescued the U-STAT1-mediated inhibition of P-STAT1 nuclear accumulation. Conclusion Our data demonstrate a novel role of U-STAT1 in affecting nuclear accumulation of P-STAT1, such that a high intracellular concentration of U-STAT1 inhibits the detection of nuclear P-STAT1 in immunofluorescence assays. These observations hint at a possible physiological function of U-STAT1 in buffering the nuclear import of P-STAT1, while preserving IFNγ-induced gene expression. Based on these results, we propose a model of a hypothetical import structure, the assembly of which is impaired under high concentrations of U-STAT1. This mechanism maintains high levels of cytoplasmic STAT1, while simultaneously retaining signal transduction by IFNγ.

<scp>N‐MYC</scp>‐interacting protein enhances type <scp>II</scp> interferon signaling by inhibiting <scp>STAT1</scp> sumoylation

SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

NMI Inhibits Cancer Stem Cell Traits by Downregulating Htert in Breast Cancer

Methyltransferase SETD2-Mediated Methylation of STAT1 is Critical for Interferon Antiviral Activity.

NMI Facilitates Influenza A Virus Infection by Promoting Degradation of IRF7 Through TRIM21.

The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc

N-Myc and STAT Interactor is an endometriosis suppressor.

Downregulated NDR1 Protein Kinase Inhibits Innate Immune Response by Initiating an Mir146a-Stat1 Feedback Loop

An inhibitory effect on the nuclear accumulation of phospho-STAT1 by its unphosphorylated form

Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis.

SENP1 Regulates IFN-γ−STAT1 Signaling Through STAT3−SOCS3 Negative Feedback Loop

MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling

Deubiquitinase USP2a Sustains Interferons Antiviral Activity by Restricting Ubiquitination of Activated STAT1 in the Nucleus

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

Nmi interacts with Hsp105β and enhances the Hsp105β-mediated Hsp70 expression

SUMO protease SENP1 deSUMOylates and stabilizes c-Myc

SENP6 restricts the IFN-I-induced signaling pathway and antiviral activity by deSUMOylating USP8

RNF220 mediates K63-linked polyubiquitination of STAT1 and promotes host defense

SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses*

Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity

RNA-mediated MYC multimerization suppresses innate immune signaling